Obinutuzumab Plus Chemotherapy As First Line Treatment in Patients with Follicular Lymphoma: Experience from a Community Hospital

被引：1
|
作者：
de Una, Soraya Lorente [1 ]
Gutierrez, Javier [1 ]
Gonzalez, Matilde [1 ]
Kumar, Anjana [1 ]
Morales, Elena [1 ]
Herrada, Juan [1 ]
机构：
[1] Hosp Vithas Xanit Int, Hematol Dept, Benalmadena, Malaga, Spain
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167896
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12001 / 12001
页数：1
相关论文
共 50 条
  • [1] Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
    Marcus, R.
    Davies, A.
    Ando, K.
    Klapper, W.
    Opat, S.
    Owen, C.
    Phillips, E.
    Sangha, R.
    Schlag, R.
    Seymour, J. F.
    Townsend, W.
    Trneny, M.
    Wenger, M.
    Fingerle-Rowson, G.
    Rufibach, K.
    Moore, T.
    Herold, M.
    Hiddemann, W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1331 - 1344
  • [2] THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY
    Hofmann, S.
    Ostwald, D. A.
    Himmler, S.
    Launonen, A.
    Duenzinger, U.
    Salmen, H.
    VALUE IN HEALTH, 2018, 21 : S37 - S37
  • [3] Management of patients with follicular lymphoma treated first line with obinutuzumab
    Opat, Stephen
    Dickinson, Michael
    Cheah, Chan Yoon
    Tam, Constantine
    Boulos, Joy
    Thorburn, Alison Nicole
    Trotman, Judith
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 3 - 11
  • [4] First-line obinutuzumab for follicular lymphoma
    Baker, Holly
    LANCET ONCOLOGY, 2017, 18 (11): : E648 - E648
  • [5] The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany
    Hofmann, Sarah
    Himmler, Sebastian
    Ostwald, Dennis
    Duenzinger, Ulrich
    Launonen, Aino
    Thuresson, Per-Olof
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 1017 - 1026
  • [6] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (07)
  • [7] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Patrick M. Reagan
    Jonathan W. Friedberg
    Current Treatment Options in Oncology, 2015, 16
  • [8] Cost-effectiveness analysis of treatment regimens with obinutuzumab plus chemotherapy in Japan for untreated follicular lymphoma patients
    Ohno, Shinya
    Shoji, Ayako
    Hatake, Kiyohiko
    Oya, Naoko
    Igarashi, Ataru
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (10) : 1130 - 1141
  • [9] Is Obinutuzumab Plus Chemotherapy Followed By Obinutuzumab Monotherapy for Previously Untreated Follicular Lymphoma Patients Cost-Effective in the US?
    Guzauskas, Gregory F.
    Masaquel, Anthony
    Thuresson, Per-Olof
    Li, Jia
    Reyes, Carolina M.
    Veenstra, David
    BLOOD, 2017, 130
  • [10] Cost-Effectiveness of Obinutuzumab Plus Chemotherapy Versus Rituximab Biosimilars Plus Chemotherapy for Patients with Previously Untreated Follicular Lymphoma
    Veenstra, David L.
    Guzauskas, Gregory F.
    Spencer, Scott J.
    Felizzi, Federico
    Launonen, Aino
    Dawson, Keith
    Masaquel, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S280 - S280
12345